Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 6

1.

Functional and genomic approaches reveal an ancient CHEK2 allele associated with breast cancer in the Ashkenazi Jewish population.

Shaag A, Walsh T, Renbaum P, Kirchhoff T, Nafa K, Shiovitz S, Mandell JB, Welcsh P, Lee MK, Ellis N, Offit K, Levy-Lahad E, King MC.

Hum Mol Genet. 2005 Feb 15;14(4):555-63. Epub 2005 Jan 13.

2.

CHEK2*1100delC genotyping for clinical assessment of breast cancer risk: meta-analyses of 26,000 patient cases and 27,000 controls.

Weischer M, Bojesen SE, Ellervik C, Tybjaerg-Hansen A, Nordestgaard BG.

J Clin Oncol. 2008 Feb 1;26(4):542-8. doi: 10.1200/JCO.2007.12.5922. Epub 2008 Jan 2. Review.

PMID:
18172190
3.

Are the so-called low penetrance breast cancer genes, ATM, BRIP1, PALB2 and CHEK2, high risk for women with strong family histories?

Byrnes GB, Southey MC, Hopper JL.

Breast Cancer Res. 2008;10(3):208. doi: 10.1186/bcr2099. Epub 2008 Jun 5. Review.

4.

The CHEK2 gene and inherited breast cancer susceptibility.

Nevanlinna H, Bartek J.

Oncogene. 2006 Sep 25;25(43):5912-9. Review.

PMID:
16998506
5.

The CHEK2 I157T variant and breast cancer susceptibility: a systematic review and meta-analysis.

Liu C, Wang Y, Wang QS, Wang YJ.

Asian Pac J Cancer Prev. 2012;13(4):1355-60. Review.

6.

Interaction between CHEK2*1100delC and other low-penetrance breast-cancer susceptibility genes: a familial study.

Johnson N, Fletcher O, Naceur-Lombardelli C, dos Santos Silva I, Ashworth A, Peto J.

Lancet. 2005 Oct 29-Nov 4;366(9496):1554-7. Review.

PMID:
16257342
Items per page

Supplemental Content

Write to the Help Desk